Skip to main content

Zika Virus Infection

2
Pipeline Programs
4
Companies
24
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Bharat Biotech
Bharat BiotechIndia - Hyderabad
1 program
1
BBV121Phase 11 trial
Active Trials
NCT04478656Completed48Est. Nov 2018
Emergent BioSolutions
1 program
1
Zika Virus Immune GlobulinPhase 11 trial
Active Trials
NCT03624946Completed30Est. Mar 2019
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Community Health WorkerN/A1 trial
Active Trials
NCT05041439Completed50Est. Nov 2022
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
SalinePHASE_15 trials
Active Trials
NCT01376765Withdrawn0
NCT05652504Suspended400Est. Nov 2026
NCT07216430Recruiting320Est. Jun 2029
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Allergy TherapeuticsSaline
Emergent BioSolutionsZika Virus Immune Globulin
Bharat BiotechBBV121
Allergy TherapeuticsSaline

Showing 15 of 23 trials with date data

Clinical Trials (24)

Total enrollment: 4,142 patients across 24 trials

Treatment of Acute Sinusitis

Start: Oct 2006Est. completion: Aug 2010172 patients
Phase 4Completed

Treating Brain Swelling in Pediatric Cerebral Malaria

Start: Jan 2018Est. completion: Dec 202357 patients
Phase 3Completed

Safety and Efficacy of wSp Vaccine in Young Children

Start: Sep 2025Est. completion: Jun 2029320 patients
Phase 2Recruiting

PfSPZ Vaccine Trial in Malian Children

Start: Apr 2022Est. completion: Dec 2022290 patients
Phase 2Completed

2017 A/H7N9 IIV Revaccination

Start: Dec 2018Est. completion: Jun 2020304 patients
Phase 2Completed

Treatment of West Nile Virus With MGAWN1

Start: May 2009Est. completion: May 201113 patients
Phase 2Terminated

Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)

Start: Jan 2019Est. completion: Jan 202110 patients
Phase 1/2Terminated

Enhancement by Poly-ICLC During HIV-1 Infection

Start: Apr 2014Est. completion: Jul 201615 patients
Phase 1/2Completed

Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests

Start: Mar 2013Est. completion: Nov 20150
Phase 1/2Withdrawn

Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

0
Phase 1Withdrawn

Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)

Start: May 2026Est. completion: Nov 2026400 patients
Phase 1Suspended

A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

Start: Jul 2023Est. completion: Mar 2027105 patients
Phase 1Active Not Recruiting

Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment Interruptions

Start: Apr 2019Est. completion: Dec 202027 patients
Phase 1Terminated
NCT03624946Emergent BioSolutionsZika Virus Immune Globulin

Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)

Start: Jun 2018Est. completion: Mar 201930 patients
Phase 1Completed

Safety and Immunogenicity of BBV121

Start: Jun 2017Est. completion: Nov 201848 patients
Phase 1Completed

Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali

Start: Oct 2016Est. completion: Jul 2020301 patients
Phase 1Completed

ZIKA Vaccine in Naive Subjects

Start: Oct 2016Est. completion: Dec 201891 patients
Phase 1Completed

Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

Start: May 2016Est. completion: Apr 201838 patients
Phase 1Completed

Phase 1 Trial of Ebola Vaccine in Mali

Start: Oct 2014Est. completion: Apr 201691 patients
Phase 1Completed

Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults

Start: Oct 201160 patients
Phase 1Completed

Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine

Start: Jan 2007Est. completion: Nov 2008300 patients
Phase 1Completed
NCT05041439Human BioSciencesCommunity Health Worker

Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico

Start: Jul 2021Est. completion: Nov 202250 patients
N/ACompleted

Hypertonic Saline Nasal Irrigation and Gargling (HSNIG) for Suspected COVID-19 in Pakistan

Start: May 2021Est. completion: Nov 2021405 patients
N/AUnknown

New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia

Start: Sep 19991,015 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 4,142 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.